{{Rsnum
|rsid=1605834
|Chromosome=2
|position=22353228
|Orientation=plus
|GMAF=0.2585
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 71.4 | 25.9 | 2.7
| HCB | 75.0 | 22.8 | 2.2
| JPT | 69.0 | 29.2 | 1.8
| YRI | 22.4 | 44.9 | 32.7
| ASW | 36.8 | 42.1 | 21.1
| CHB | 75.0 | 22.8 | 2.2
| CHD | 70.6 | 27.5 | 1.8
| GIH | 76.2 | 22.8 | 1.0
| LWK | 22.7 | 47.3 | 30.0
| MEX | 51.7 | 43.1 | 5.2
| MKK | 20.6 | 51.0 | 28.4
| TSI | 60.8 | 37.3 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=20889312
  |Trait=Bipolar disorder and schizophrenia
  |Title=A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder.
  |RiskAllele=
  |Pval=8E-6
  |OR=1.32
  |ORtxt=[NR]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}